Fulvestrant Survival Advantage in Advanced Breast CancerFulvestrant Survival Advantage in Advanced Breast Cancer

New survival data from the FIRST trial show a survival advantage for the injectable fulvestrant over the standard of care, oral anastrozole. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news